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Abstract
Background: Alzheimer’s disease (AD) is a major neurodegenerative disorder leading to amnesia, cognitive
impairment and dementia in the elderly. Usually this type of lesions results from dysfunctional protein cooperations
in the biological pathways. In addition, AD progression is known to occur in different brain regions with particular
features. Thus identification and analysis of crosstalk among dysregulated pathways as well as identification of their
clusters in various diseased brain regions are expected to provide deep insights into the pathogenetic mechanism.
Results: Here we propose a network-based systems biology approach to detect the crosstalks among AD related
pathways, as well as their dysfunctions in the six brain regions of AD patients. Through constructing a network of
pathways, the relationships among AD pathway and its neighbor pathways are systematically investigated and
visually presented by their intersections. We found that the significance degree of pathways related to the fatal
disorders and the pathway overlapping strength can indicate the impacts of these neighbored pathways to AD
development. Furthermore, the crosstalks among pathways reveal some evidence that the neighbor pathways of
AD pathway closely cooperate and play important tasks in the AD progression.
Conclusions: Our study identifies the common and distinct features of the dysfunctional crosstalk of pathways in
various AD brain regions. The global pathway crosstalk network and the clusters of relevant pathways of AD
provide evidence of cooperativity among pathways for potential pathogenesis of the neuron complex disease.
Background
Recently, systems biology approaches such as
network-based methods have been successfully applied
to elucidate the mechanism of diseases [1-3]. For
instance, human transcriptome and interactome can be
integrated to bridge the gap between genotype and phe-
notype [4-6]. Alzheimer’s disease (AD) is a debilitating
neurodegenerative progression and fatal disease. The
genetic mechanisms of AD are far from being clear
although there are several popular hypotheses about its
pathogenesis [7-9]. The availability and integration of
high-throughput gene expression data [10] and the
genome-wide protein-protein interaction may shed new
lights on AD study.
Biological processes in a cell are carried out through
interactions among many proteins [11], which are func-
tional units and generally achieve specific tasks coopera-
tively [2]. In other words, the activities of proteins are
organized into modules that form many pathways.
Often, genes in the same pathway are activated together
and thus exhibit similar gene expression patterns. And
genes with similar expression profiles are more likely to
encode interacting proteins to coordinately achieve a
particular function [11,12]. Regarding to AD, a key chal-
lenge is to identify the biological processes or signaling
pathways which play significant roles in the develop-
ment of disease. Here, we aim to integrate the interre-
lated transcriptomic and interactomic information
together to investigate AD related pathways.
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cooperations of proteins in the form of pathways but
also the interactions of pathways, i.e., the crosstalks of
these pathways [13,14]. Here crosstalk is defined as the
fact that two pathways are likely to interact with or
influence each other. Crosstalk between pathways pro-
vides more complex nonlinear responses to combina-
tions of dysfunctions [15,16]. To study pathogenesis of
AD, some studies show that the gradual cognition
decline may correspond to disease progression in differ-
ent brain regions responsible for certain independent
functions individually [17]. Neuronal loss occurred in
AD often begins from a deep brain region, i.e. entorh-
inal cortex, and then spread to the hippocampus [10,17],
a key part of brain controlling memories and move-
ments. From the systematic perspective, analysis of AD
related bio-molecular interaction networks in different
brain regions will improve the understanding of the
complexity of molecular pathways underlying AD phe-
notypes and will help to uncover the dynamic processes
of disease progression.
In this paper, we focus on the spatial pathway clusters
in different AD brain regions and the crosstalks among
pathways by integrating protein-protein interaction
(PPI) and gene expression data. Specifically we define
dysfunctions of pathway as the responsive scores of
these involved protein interactions from control cases to
disease cases. Currently, several computational methods
[2] have been proposed to detect active pathways, and
those methods are designed to find differentially
expressed gene sets [18,19] and the corresponding pro-
tein sets, and then these differentially scored proteins
with all their reported interactions are taken as dysregu-
lated pathways [20,21]. However, we note that the infor-
mation on protein interaction gives not only an outline
of protein relationship [22,23], but also the possibility of
dysfunctional cooperations in disease. The known inter-
actions of these disease proteins can then be used to
detect the specific dysfunctions by combining with other
information, e.g., the expression of genes and the corre-
lation between them [24-26].
To this end, we propose a network-based analysis for
the crosstalks among AD related pathways in different
AD brain regions by integrating protein-protein interac-
tions and region-specific gene expression profiles. Initi-
ally, we build a protein network of pathways by collecting
KEGG AD pathway and its neighbor pathways. Then, we
propose a new scoring scheme to define the dysfunctions
of protein interactions by combining gene expression and
co-expression information. The crosstalks of these dys-
functional pathways are identified by their overlapping
relationship in six AD brain regions. In addition, we clus-
ter AD related pathways into groups by their significance
of overlapping and the related pathways are sorted by
their scores of dysregulation. Finally, we demonstrate
that the brains process comprehensive crosstalk between
pathways on the protein level due to AD progression in
various regions.
Results
Clusters of AD related pathways
We built a network of pathways by integrating the
pathway information from KEGG [27] and the protein-
protein interaction network. The gene set of KEGG AD
pathway and that of all its neighbor pathways were
mapped to the ensemble protein-protein interaction
network (see Methods). Figure 1(a) shows the protein-
protein interaction network where the genes in the
KEGG AD pathway are highlighted in red. Then we
plotted the pathway as nodes and linked two pathways
by an edge if the two pathways have overlapping genes.
Figure 1(b) shows the global topology linkages of AD
pathway and its neighbor pathways. The red node in
Figure 1(b) corresponds with the red part of AD path-
way in Figure 1(a).
After weighting the network edges by integrating gene
expression and co-expression data in six AD brain
regions (see Methods), we can evaluate if the interac-
tions among pathways are significant. The overlapping
score and its significance can be used as a measurement
of close relationship among them. Then a similarity
matrix of these pathways was built and used to group
the pathways into clusters. Figure 2 gives the clustering
result in these pathways based on their interaction sig-
nificance in EC region. We then did the similar cluster-
ing for these pathways in the other five regions. Table 1
lists the results of the cluster in which KEGG AD path-
way is grouped. In Figure 2, different colored clusters
describe different modules. The red cluster is the mod-
ule of KEGG AD pathway (ID: hsa05010) and its closest
interaction pathways. The modules in grey color are the
part of pathways which cannot be grouped to any indivi-
dual cluster distinctly. We found that several pathways
of neurodegenerative diseases were grouped together,
such as Parkinson’s disease (hsa05012), Huntington’s
disease (hsa05040) and Dentatorubropallidoluysian atro-
phy (hsa05050). The significant interaction between two
pathways provides evidence for their close interrelations.
This result indicates the close relationship between
these neuron diseases. Pathway modules in other brain
regions are similar to those in EC region (results are
s h o w ni nT a b l e1 ) .T h e s er e sults not only provide us
evidence for the close relationship between AD and
related neuron diseases [28], but also validate the effec-
tiveness of our method. Moreover, we also identified
some closely related pathways with AD in the same
cluster, e.g., Oxidative phosphorylation (hsa:00190), p53
signaling pathway (hsa04115), and Apoptosis (hsa04210).
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is closely related to AD [29]. Functionally important
reductions in oxidative phosphorylation enzyme activities
appear to occur in AD and may be related to b-amyloid
accumulation, which is the main phenotype in AD patient
brains [29]. Thus this kind of dysfunction defects could
play an important role in the pathophysiology of AD. The
critical role of p53 is proved by the fact that it is mutated
in a very large fraction of tumors [30]. It is an important
transcriptional activator whose activity is regulated by
phosphorylation. p53 is also known as a potential biomar-
ker for AD for its special alternation presented in Ab accu-
mulation [30]. The signaling pathway can cause the cell to
enter apoptosis process (pathway ID: hsa04210). The
brains of AD patients contain dying neurons displaying
apoptosis. The close relationship between pathways of
apoptosis and AD indicates that apoptosis plays an impor-
tant role in the progression of the disease. From this view-
point, the therapies of AD need consider the apoptosis
features of the neuron cell. The clusters of AD related
pathways provide us a global view of the relationships
among these pathways. The category also clearly indicates
the close dysfunctional pathways related to AD in various
brain regions.
Dysfunctional crosstalk between pathways
From the clusters, we identified the pathway modules
with close relationships. The crosstalk of dysregulated
pathways exist not only in the same clusters of pathway,
but also exist within all its neighbor pathways. As to
these AD related pathways, we defined the dysfunction
score and its significance criterion (see Methods). We
individually identified the significance of their
dysfunctions in six AD brain regions. Table 2 lists the
top five ranked pathways in every region. The dysfunc-
tion score of every pathway neighbored to AD pathway
represents the activation status during the AD progres-
sion in the form of pathway of protein interactions. We
found that Apoptosis (hsa04210), Notch signaling path-
way (hsa04330), Wnt signaling pathway (hsa04310), and
Cytokine-cytokine receptor interactionare (hsa04060)
are the most significant pathways in the six regions.
F r o mt h er a n k ,w eg a v eaq u a n t i t a t i v em e a s u r eo ft h e
dysfunctional activation of these neighbor pathways
when AD pathway performs its dysfunctions of neuron-
toxic processes. Among the pathways in the clusters
containing AD pathway, we can find that some of them
are also the most significant pathways. Apoptosis is not
only with high interaction significance with AD pathway,
but also with high dysfunction significance itself. The
result gives more evidence for the strong relationship
between apoptosis and AD process [31]. Especially,
Notching signaling pathway is twice ranked as the first
in the six regions. The pathway is known to be crucial
in communication between the cells, which involves
important processes during embryonic and adult life
[32]. When developing medicines for AD, the side effect
for Notch signaling pathway is an important factor
because it may inhibit the drug targets. Wnt signaling
pathway often involves in Ca
2+ signaling, which leads to
transient increases in cytoplasmic free calcium that sub-
sequently activates the calcium kinase and the phospha-
tase calcineurin [27]. It is now known that the Ca
2+i s
often crucial to AD, which is regarded as the calcium
hypothesis [33]. If the calcium level is not properly con-
trolled, it would lead to neuron cell dysfunction and
Figure 1 Network of pathways. Subfigure (a) shows the ensemble protein-protein interaction network in which the proteins of KEGG AD
pathway and its neighbor pathways are involved. AD pathway is highlighted in red. Subfigure (b) shows the topological linkages among the AD
pathway and its neighbor pathways, where node denotes pathway and there is an edge if two pathways contain at least one common protein.
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Page 3 of 12death. Calcium flows into brain cells in an unregulated
way and affects cell function and survival. Cytokines are
also crucial to cell death. Proinflammatory cytokines
may lead to neuron death and dysfunction by variant
mechanisms. Inhibition of cytokines has been tested as a
therapy method for the treatment of AD [34]. In sum-
mary, the significant neighbor pathways indicate the
dysfunctional crosstalk between those pathways and AD
pathway. The critical influences to AD were identified
from the neighbor pathways.
The rank of dysfunctional significance implies the
degree of inflections from neighbor pathways to AD
pathway. In EC region, there are several other dysfunc-
tionally significant neighbors in addition to the top 5
pathways in Table 2. The crosstalk status between AD
related pathways are shown in Figure 3, where the center
node is the AD pathway and the others are its neighbor
pathways. The interaction significance of two pathways is
represented by the width of their edge. The dysfunction
significance of a pathway is shown by the corresponding
gradient node color. The node size represents the num-
ber of proteins involved in the pathway. From Figure 3,
we can clearly detect the two indices of describing the
crosstalk between pathways, i.e., the intra-pathway dys-
function score and inter-pathway interaction strength.
Oxidative phosphorylation pathway (hsa00190) signifi-
cantly interacts with AD pathway (hsa05010), Cytokine-
cytokine receptor interaction pathway (hsa04060), Cal-
cium signaling pathway (hsa04020), and p53 signaling
pathway (hsa04115). The calcium signaling pathway pro-
vides evidence for the dysfunctional relationship between
calcium with AD mechanism [33]. Interestingly, some of
them also have significant interactions with each other
which constitute a module formation in these neighbor
pathways. We note that the pathways in the module are
mainly contained in the same cluster of Figure 2. The
pathway clusters in neighbor pathways are also the coop-
erative group with dysfunctional crosstalk to AD path-
way. This implies the complexity of the
neurodegenearative disease and provides new hypotheses
of AD. As to the crosstalk of GO [35] functional relation-
ships between these pathways, we identified the accumu-
lative hypergeometric significant GO biological processes
in every pathway. The functional enrichment among pro-
teins in one pathway is defined as:
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where n is the number of nodes in the network, ƒ is
the number of proteins annotated with a particular GO
function, m is the number of proteins involved in the
pathway and k i st h ef r e q u e n c yo ft h eG Ot e r m .W e
identified the GO function enrichment of the pathways
in six brain regions respectively. The results of the top
three GO terms in part of the pathways are shown in
Figure 4. The most significant biological processes in
AD pathway are proteolysis (GO:0006508), membrane
protein ectodomain proteolysis (GO:0006509) and elec-
tron transport chain (GO:0022900). The functions
Figure 2 Hierarchical clustering of pathways in EC region.
Different modules are represented by different colors. The red one
represents the cluster including KEGG AD pathway (hsa:05010). The
grey ones are those pathways which can not be clearly clustered
into groups. The detailed clustering results are listed in Table 1.
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AD progression. The significant functions of neighbor
pathways provide a flow of transporting of molecules
(macromolecules, small molecules, protons and other
ions) of substances into, out of, within, or between cells
(GO:0006810, GO:0015992). Other pathways introduce
one or more phosphate groups into a phosphoinositide
(GO:0046854). Especially, Apoptosis pathway (hsa04210)
enriches the conversion of proteins, and induces or sus-
tains apoptosis to an active form (GO:0008633). From
the significant GO enrichments, we know the crosstalk
of GO biological processes during the disease develop-
ment between the pathways in various brain regions.
The most popular hypotheses of AD mechanism is the
amyloid cascade hypothesis and tau hypothesis, and the
disease is caused by the accumulation of abnormally
folded Aß and tau proteins in the brain [29]. The GO
significance among these pathways provides high
correlated functions in these pathways which provide
implications that the closely related pathways are crucial
to the dysfunction of AD pathway during the disease
progression.
Discussion
In this work, we identified the dysfunctional crosstalk
of AD related pathways in different brain regions
based on a novel network-based method. In the AD
protein network, we first built the network of pathways
by integrating KEGG pathways information and pro-
tein-protein ensemble interactions. The crosstalk of
pathways underlying their interaction significance and
their dysfunctional score were detected by correspond-
ing gene transciptome information in six disease brain
regions respectively. The analysis of dysfunctional
crosstalk with AD pathway is based on the pathway
clusters and all its neighbor pathways as well as their
Table 1 Clusters of KEGG AD pathway (hsa05010) in different brain regions
Region Pathway ID Size Edge Node P-value Description
EC hsa00190 137 7 12 0.115269 Oxidative phosphorylation
hsa04110 119 344 101 1.000000 Cell cycle
hsa04115 69 72 46 0.146277 p53 signaling pathway
hsa05012 136 25 26 0.130562 Parkinson’s disease
hsa05040 32 27 21 0.207717 Huntington’s disease
hsa05050 15 10 11 0.213708 Dentatorubropallidoluysian atrophy (DRPLA)
HIP hsa04080 302 106 128 0.815693 Neuroactive ligand-receptor interaction
hsa04115 69 72 46 0.362224 p53 signaling pathway
hsa04720 72 37 32 0.117635 Long-term potentiation
hsa04730 75 41 38 0.025842 Long-term depression
hsa05050 15 10 11 0.347488 Dentatorubropallidoluysian atrophy (DRPLA)
MTG hsa04360 129 100 72 0.094750 Axon guidance
hsa04370 74 54 41 0.672299 VEGF signaling pathway
hsa05014 56 35 28 0.853204 Amyotrophic lateral sclerosis (ALS)
hsa05040 32 27 21 0.707504 Huntington’s disease
hsa05050 15 10 11 0.719474 Dentatorubropallidoluysian atrophy (DRPLA)
PC hsa04210 89 156 72 0.195914 Apoptosis
hsa04730 75 41 38 0.880031 Long-term depression
hsa05040 32 27 21 0.084885 Huntington’s disease
hsa05050 15 10 11 0.056018 Dentatorubropallidoluysian atrophy (DRPLA)
SFG hsa04010 274 403 188 0.082078 MAPK signaling pathway
hsa04360 129 100 72 0.094750 Axon guidance
hsa04370 74 54 41 0.344348 VEGF signaling pathway
hsa05014 56 35 28 0.257644 Amyotrophic lateral sclerosis (ALS)
hsa05040 32 27 21 0.505385 Huntington’s disease
VCX hsa00190 137 7 12 0.197734 Oxidative phosphorylation
hsa05012 136 25 26 0.291280 Parkinson’s disease
hsa05040 32 27 21 0.518223 Huntington’s disease
hsa05050 15 10 11 0.516887 Dentatorubropallidoluysian atrophy (DRPLA)
“Size” is the number of genes contained in KEGG gene sets. “Edge” and “Node” represent the number of edges and nodes of these pathways in our protein-
protein interaction network with gene expression information. “P-value” gives the p-value of dysregulation score of every pathway in the cluster. “Description”
gives the pathway name.
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Page 5 of 12clusters related to AD pathway. Some of the identified
dysfunctional crosstalk between the pathways are con-
sistent with our knowledge for AD. Some of them pro-
vides valuable alternatives for AD mechanism,
especially from the pathway relationship perspective.
The interaction of these dysfunctional pathways pro-
vides more insights for the AD progression in various
brain regions.
Closely related pathways of AD
When identifying the crosstalk between the pathways in
AD disease brain regions, we only chose AD pathway
and its neighbor pathways. Temporarily, many impor-
tant pathways in KEGG were not considered in this
study if they do not contain overlapped genes with the
AD pathway. In other words, we only studied the neigh-
bor pathways with direct interaction with AD pathway.
The strategy is based on the straightforward assumption
that the nearest neighbor pathways imply the close
relationship with AD pathway. We acknowledge that the
pathways with indirect interactions with AD pathway
might also transfer potential dysfunctions to AD and
then are important for the pathway clusters and dys-
functional processes. These pathways should be further
explored in future.
Additionally, our method can be similarly applied to all
the annotated pathways. Moreover, clustering of those
AD related pathways into pathway clusters provide more
information. The similar clusters in different brain
regions show that the crosstalks among these pathways
are relatively consistent in different brain tissues. This
indicates the common or identical dysfunctions in var-
ious AD brain regions. The clusters containing AD path-
way imply that the neurodegenerative diseases have close
relationships, which provide evidence for the effective-
ness of our method.
Table 2 Rank of AD related pathways
Region Pathway ID Size Edge Node P-value Description
EC hsa04210 89 156 72 0.000001 Apoptosis
hsa04060 279 259 220 0.000002 Cytokine-cytokine receptor interaction
hsa04620 102 110 69 0.000695 Toll-like receptor signaling pathway
hsa05220 75 181 69 0.003802 Chronic myeloid leukemia
hsa05120 68 54 40 0.003899 Epithelial cell signaling in Helicobacter pylori infection
HIP hsa04310 152 152 83 0.000000 Wnt signaling pathway
hsa05214 65 113 52 0.000000 Glioma
hsa04060 279 259 220 0.000001 Cytokine-cytokine receptor interaction
hsa04012 87 200 71 0.000002 ErbB signaling pathway
hsa05215 90 181 72 0.000002 Prostate cancer
MTG hsa04330 46 59 34 0.000000 Notch signaling pathway
hsa05120 68 54 40 0.000000 Epithelial cell signaling in Helicobacter pylori infection
hsa04310 152 152 83 0.000003 Wnt signaling pathway
hsa04520 78 105 59 0.000024 Adherens junction
hsa04210 89 156 72 0.000388 Apoptosis
PC hsa04060 279 259 220 0.000000 Cytokine-cytokine receptor interaction
hsa04640 87 49 62 0.000000 Hematopoietic cell lineage
hsa04115 69 72 46 0.000049 p53 signaling pathway
hsa04210 89 156 72 0.000689 Apoptosis
hsa05217 55 33 26 0.001264 Basal cell carcinoma
SFG hsa04330 46 59 34 0.000000 Notch signaling pathway
hsa04510 203 340 150 0.000000 Focal adhesion
hsa04920 67 79 39 0.000002 Adipocytokine signaling pathway
hsa04210 89 156 72 0.000009 Apoptosis
hsa05120 68 54 40 0.000190 Epithelial cell signaling in Helicobacter pylori infection
VCX hsa04060 279 259 220 0.000000 Cytokine-cytokine receptor interaction
hsa04640 87 49 62 0.000000 Hematopoietic cell lineage
hsa04340 57 14 11 0.000121 Hedgehog signaling pathway
hsa04510 203 340 150 0.000279 Focal adhesion
hsa04662 65 93 51 0.002533 B cell receptor signaling pathway
The most significant 5 pathways in six AD brain regions are ranked individually by “P-value”, which gives the p-value of dysregulation of the pathways. “Size”
presents the number of genes contained in KEGG gene sets. “Edge” and “Node” represent the number of edges and nodes of these pathways.
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We collected AD related gene sets of pathway and
linked the genes by our integrated PPI network. Then
we mapped the region-specific gene expression profiling
to the protein interaction network. The edges are scored
by the Fisher’s method by combining the statistical sig-
nificance p-values of differential expression and co-
expression. The dysfunctions between two proteins are
simultaneously evaluated by their gene expression and
correlation in various disease brain regions individually.
The edge-scoring scheme considers the differential
expression from the control to the disease and the cor-
relation information in the disease cases. The meta-ana-
lysis is applied to integrate p-values between the
interacting proteins with independence assumption [36].
In the light of performing functions by protein interac-
tions, dysfunctions of protein interaction are represented
from the expression and correlation level of two pro-
teins. Then the dysfunctional importance of the path-
ways are their dysregulation underlying the interactions
and the quantitative significance. We defined the dysre-
gulation score of pathways by summarizing the scores of
contained interactions. And the overlapping score
between two pathways is the summary of edge scores
on their common interactions. Moreover, the scores
have been normalized by transforming into statistical
significance values [37]. The dysfunction scores of the
pathways and the interaction scores between the
pathways are used for identifying the crosstalk.
Crosstalk among the pathways
We clustered AD and its neighbor pathways by their
statistical significance of overlapping scores. The inter-
action significance are represented as a distance matrix.
From hierarchical clustering, we identified the pathway
correlations and detected their relationship in six AD
brain regions respectively. We identified the crosstalk of
these pathways in the clustered groups as well as with
their neighbor pathways, especially with AD pathway.
The crosstalk between pathways other than AD pathway
might also contribute to AD by their cooperative dys-
functions. In this paper, we considered the nearest
neighbor pathways with AD pathway. A future research
direction is to identify the dysfunction of indirect inter-
action between one pathway and AD pathway. More-
over, the crosstalk with AD pathway is not only related
to the interaction, but also related to their own dysfunc-
tions. We identified the significant dysfunctions of the
Figure 3 Dysfunctional crosstalk of AD related pathways. The center dark node is the KEGG AD pathway and other nodes are its neighbor
pathways. The size of the nodes represents the number of proteins contained in the pathways. The width of the edges represents the
significance of dysfunctional relationship between the two pathways in EC region. The color of the nodes represents the dysfunction significance
of these neighbor pathways in EC region.
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with high interaction significance with AD pathway.
These pathways are important for the dysfunctional
crosstalk with AD process during the development in
various brain regions. We identified the crosstalk among
these pathways and provided detailed analysis of the
interactive dysfunctions with AD pathway. We also
identified the biological processes enrichments underly-
ing these interacted pathways. The GO functional lin-
kages of these pathways provided more implications for
their dysfunctional crosstalk.
Regional feature of crosstalk
We identified the pathway clusters in six functionally
important brain regions respectively. There are some
regional features of the crosstalk, such as the difference
of the rank of pathways in Table 2. We focused on both
the similarity among the pathway clusters and the specifi-
city in every cluster. The mechanism of AD dysfunction
might underlie the common features, while the regional
feature would be the biomarker for the specific diseased
tissues. The comparison of pathway clusters and then the
dysfunctional difference in different regions gives more
knowledge of the status of protein cooperativity in speci-
fic brain region. The decline of normal activity abilities is
known to be controlled by different brain regions [17],
and then the specificity would also provide detailed infor-
mation for the dysfunctions.
Conclusion
In this paper, a network-based approach was used to ana-
lyze the crosstalks among AD related pathways. The clus-
ters of pathways were identified and the related pathways
were ranked by their dysfunctional scores. The dysfunc-
tional crosstalks of pathways are found and analyzed in six
AD brain regions. The results are consistent with our prior
knowledge of AD. The crosstalk of pathways presents new
alternative insights for AD pathology. Our work shows that
comprehensive and system-wide analysis provides evidence
for neurodegenerative AD disorder and complements the
traditional component-based approaches.
Methods
Data sources
We downloaded the AD pathway and all its neighbor
pathways from KEGG. Here the neighbor pathways are
defined as those pathways which have at least one over-
lapping gene with AD pathway. In total there are 77
neighbor pathways in KEGG intersecting with AD path-
way (see Additional file 1). Figure 5(a) shows the
hsa:05010
0006508  33/12  6.79e-10
0006509 8/7 1.41e-08
0022900 7/6 3.90e-07
hsa:05012
0022900 7/6 4.49e-14
0006810 18/8 2.08e-13
0008635 4/3 3.08e-08
hsa:00190
0015992 8/6  2.45e-10
0022900 7/5 3.54e-08
0006810 18/6 3.64e-08
hsa:04115
0051301 45/13  1.98e-10
0007049 77/14 1.39e-08
0001836 9/6 8.97e-07
hsa:04920
0006633 39/13 4.90e-09
0046320 148/21 1.30e-07
0006006 19/9 1.37e-07
hsa:04620
0006954 89/20 9.22e-11
0043123 33/11 1.27e-07
0032496 6/6 3.67e-07
hsa:05040
0006886 5/3  1.21e-03
0016192 7/3 2.50e-03
0006508 33/4 5.54e-03
hsa:05050
0046718 5/3 3.19e-04
0006464 18/3 4.68e-03
0006508 33/3 1.54e-02
hsa:04210
0008633  18/14 1.22e-15
0043123 33/14 4.90e-11
0042981 36/12 4.01e-08
hsa:04060
0006508  89/58 6.17e-53
0006935 66/49 1.37e-33
0006954 143/89 6.85e-35
hsa:05222
0046854 5/5 7.69e-06
0042981 36/9 2.64e-05
0000082 19/7 3.39e-05
Term Description
GO:0006508 proteolysis
GO:0006509 membrane protein
ectodomain proteolysis
GO:0022900 electron transport chain
GO:0006954 inflammatory response
GO:0006810 transport
GO:0015992 proton transport
GO:0046718 entry of virus into host cell
GO:0006886 intracellular protein
transport
GO:0051301 cell division
GO:0008633 activation of pro-apoptotic
gene products
GO:0006633 fatty acid biosynthetic
process
GO:0046854 phosphoinositide
phosphorylation
KEGG Pathway ID
GO term #network / #pathway P-value
Figure 4 The top three GO functions which are enriched in the crosstalks among the dysfunctional pathways. Significantly enriched GO
biological processes are identified in every pathway respectively. The nodes are the pathways with significantly enriched GO annotations.
Pathway ID, GO terms, number of the GO terms in the network/pathway, and hypergeometric p-values are presented in nodes. The description
of the node and GO terms are shown on the right part. The one in the center is the AD pathway.
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Page 8 of 12schematic representation for this procedure. We then
mapped all the genes to proteins from NCBI [38] and
represented them by their NCBI Entrez Gene IDs. Then
we applied a voting method to construct an ensemble
protein-protein interaction network by integrating five
existing PPI databases in human, i.e., HPRD [39], BIND
[40], BioGrid [41], IntAct [42], and MINT [43]. Roughly
we selected those interactions contained in at least three
of the five databases. The comprehensive protein-pro-
tein interaction network contains 7,533 nodes and
22,345 edges.
We extracted the gene expression profile data on AD
patients with normal controls from [10], which were
deposited in NCBI GEO [44] database (ID:GSE5281). The
expression data were used to study AD progression in six
functionally and anatomically distinct brains regions [10],
including entorhinal cortex (EC), hippocampus (HIP),
middle temporal gyrus (MTG), posterior cingulate cortex
(PC), superior frontal gyrus (SFG), and visual cortex
(VCX). We preprocessed the CEL source files by RMA
algorithm with defaulted parameters in R bioconductor
package [45]. Probe sets were mapped to NCBI entrez
Figure 5 Schematic representation of identifying and analyzing the crosstalk of dysfunctional pathways in six AD brain regions. (a)
Gene sets of AD pathway and its neighbor pathways are identified from KEGG; (b) Networking the proteins by the integrated PPI from five
known databases and mapping the region specific gene expression profiling information to the network of pathways; (c) Identifying the
relationships among AD related pathways in six brain region and clustering them into groups respectively; (d) Ranking these pathways by
dysfunctional score.
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Page 9 of 12genes using DAVID [46]. If there are multiple probe sets
that correspond to the same gene, the expression values of
those probe sets are averaged. The expression dataset con-
tains 22,283 probes and, as a result, leads to 13,932 genes.
Temporarily, these genes without corresponding proteins
in the integrated PPI network and corresponding gene in
the expression experiments were not included in the ana-
lysis as well as the isolated proteins in every pathways.
This ended up with an KEGG AD pathway with 54 nodes
and 79 edges and 70 neighbor pathways. The network of
all these pathways contains 1,401 proteins and 2,888 inter-
actions (see Additional file 2). All the source data are in
the version of September 2008.
Mapping gene expression to PPI network
To measure the differential expression status of gene,
we used Welch’s t-test to calculate the p-value from the
expression data of control and disease cases. To deter-
mine the co-expressed significance of a gene pair in dis-
ease cases, we used the Pearson correlated coefficient
test to calculate the p-value. Then we mapped those p-
values to the nodes and edges in the protein-protein
interaction network (Figure 5(b)). Fisher’s method [36]
is used to define a function as the combination of statis-
tical significance of an interaction by a scoring scheme
in the following formula:
S diff corr diff exy f x xy y
p ei i
k
,, , ,
log ,
() () = () ( ) () ()
=− ()
= ∑ 2
1
where diff(x) and diff(y) are differential expression
assessments of gene x and gene y, respectively. corr(x‚y)
represents their correlation between gene x and gene y.
f is a general data integration method that can handle
multiple data sources differing in statistical power.
Where k =3 ,p1 and p2 are the p-values of differential
expression of two nodes, p3 is the p-value of their co-
expression. The gene profiles for different specific
regions of AD were mapped respectively and we
obtained six condition-based weighted protein interac-
tion networks (see Figure 5(b)).
Interaction significance between pathways
We define an interaction function to evaluate the signif-
icance of all non-empty overlaps between two pathways
in different brain regions individually, i.e.,
OPP i j S O ij i j ij =∈ ≠ ∅  ,, ,
where Pi and Pj are two pathways, and Oĳ is their
overlapping. Specifically, the interaction score between
two pathways is estimated by their overlapping status of
weighted pathways in the following formula:
CPP Se ij
eO ij
,. () = ()
∈ ∑
The overlapping score is the summation of the scores
of overlapping edges between pathways. To estimate the
significance of the overlapping between different disease
brain regions, we random sample 10
6 times of the same
size two pathways in the edges of pathway network and
calculate their overlapping scores. The frequency larger
than C is regarded as the interaction significance p-
value. From the scores, a distance matrix of these path-
ways is built and used to clustering these pathways into
pathway groups. Hierarchical clustering is implemented
for grouping the pathways into clusters by using the
dynamicTreeCut package in R [45] (see Figure 5(c)).
Dysregulation of related pathways
To define the dysfunction of a pathway P in various
regions of AD, we summarize all the scores of edges S
(e) of every pathway, i.e.,
SS e P
eP
= ()
∈ ∑
. To estimate a p-value for significance of this path-
way, we iteratively compute similar scores 10
6 times on
randomly generated pathways of the same size as that of
pathway P. The frequency of scores that are larger than
Sp is used as the significance p-value of pathway P to
describe its dysregulation in one specific brain region. In
every region, we get a ranked list of dysfunctional path-
ways (see Figure 5(d)). The detailed analysis of crosstalk
of dysfunctional relationship among pathways is then
investigated, especially that with AD pathway.
Additional file 1: Description of AD related pathways.
Additional file 2: Source data of the constructed protein network of
pathways.
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